跳至主要内容
临床试验/IRCT20180406039205N1
IRCT20180406039205N1招募中3 期

Investigation of pyridoxine effect on behavioral adverse events of levetiracetam in adult patients with idiopathic generalized tonic-clonic epilepsy; A randomized double-blind placebo-controlled clinical trial

Sari University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age >=18 years
  • Patients affected by idiopathic generalized epilepsy
  • Patients who are treated by levetiracetam (Levebel, Cobel darou) in recent month
  • Complaint of behavioral problem
  • Patient's consent for participation

排除标准

  • History of known psychiatric disease
  • Incidence of psychotic side effects including hallucination, psychosis, suicidal idea or attempt
  • Treatment with psychiatric medications
  • Alcohol or drug abuse
  • Mental retardation to the degree that intervenes comprehension and response to questionnaire

研究者

发起方
Sari University of Medical Sciences

相似试验